rxstat › Shortages › Albumin

Albumin (Draximage Maa) shortage status

Widespread shortage Tier 3: critical

Source: Health Canada shortage reports · Updated Oct 5, 2026

Albumin is in a widespread shortage in Canada. 1 of 1 reported products are affected, and Health Canada has designated this a Tier 3 (most serious) shortage. The latest manufacturer estimate for full recovery is Jan 31, 2027.
Products affected
1 / 1
In shortage since
Jul 30, 2026
Est. full return
Jan 31, 2027
Reports on file
2
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
DRAXIMAGE MAA
2.5MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
DIN 02329417 · since Jul 30, 2026, est. end Jan 31, 2027 · Disruption of the manufacture of the drug.
Resolved
DRAXIMAGE MAA
2.5MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
DIN 02329417 · ended Dec 21, 2021 · Delay in product release.

What's happening

Albumin is currently affected by an active shortage report filed with Health Canada by JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

Health Canada has flagged this as a Tier 3 shortage, its most serious category, meaning the shortage has the greatest potential impact on the health system and alternatives are limited.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Albumin is classified under “BLOOD AND RELATED PRODUCTS” (ATC B05AA).

Recent changes

Common questions

When will Albumin be back in stock in Canada?

The latest manufacturer estimate is Jan 31, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Albumin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (blood and related products)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Dextrose Dextran (Lmd) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.